KR20180067603A - Acc 억제제 및 그의 용도 - Google Patents
Acc 억제제 및 그의 용도 Download PDFInfo
- Publication number
- KR20180067603A KR20180067603A KR1020187013132A KR20187013132A KR20180067603A KR 20180067603 A KR20180067603 A KR 20180067603A KR 1020187013132 A KR1020187013132 A KR 1020187013132A KR 20187013132 A KR20187013132 A KR 20187013132A KR 20180067603 A KR20180067603 A KR 20180067603A
- Authority
- KR
- South Korea
- Prior art keywords
- independently selected
- nitrogen
- sulfur
- heteroatoms independently
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 C*([n]1nccn1)=C Chemical compound C*([n]1nccn1)=C 0.000 description 21
- ZZSJUEWJLXGBQE-CDSUDZIVSA-N C/C=C/CCOC(CN(c([s]c(-[n]1nccn1)c1C)c1C(N1[C@@H](CCN2C)C2=O)=O)C1=O)c1cc(F)ccc1OC Chemical compound C/C=C/CCOC(CN(c([s]c(-[n]1nccn1)c1C)c1C(N1[C@@H](CCN2C)C2=O)=O)C1=O)c1cc(F)ccc1OC ZZSJUEWJLXGBQE-CDSUDZIVSA-N 0.000 description 1
- UOMFGVFGLMRDEV-UHFFFAOYSA-N CC(C)N(CCC1N(C(c2c(N3)[s]c(-[n]4nccn4)c2C)=O)C3=O)C1=O Chemical compound CC(C)N(CCC1N(C(c2c(N3)[s]c(-[n]4nccn4)c2C)=O)C3=O)C1=O UOMFGVFGLMRDEV-UHFFFAOYSA-N 0.000 description 1
- NWYOHBLLZDTKHT-GITCGBDTSA-N CC(C)N(CCC1N(C(c2c(N3C[C@@H](c(cc(cc4)F)c4OC)OC4CCOCC4)[s]c(-[n]4nccn4)c2C)=O)C3=O)C1=O Chemical compound CC(C)N(CCC1N(C(c2c(N3C[C@@H](c(cc(cc4)F)c4OC)OC4CCOCC4)[s]c(-[n]4nccn4)c2C)=O)C3=O)C1=O NWYOHBLLZDTKHT-GITCGBDTSA-N 0.000 description 1
- GVJKRJYEULLCOZ-IAXKEJLGSA-N CC(C)N(CCC1N(C(c2c(N3C[C@@H](c4cc(F)ccc4OC)OCCOC)[s]c(-[n]4nccn4)c2C)=O)C3=O)C1=O Chemical compound CC(C)N(CCC1N(C(c2c(N3C[C@@H](c4cc(F)ccc4OC)OCCOC)[s]c(-[n]4nccn4)c2C)=O)C3=O)C1=O GVJKRJYEULLCOZ-IAXKEJLGSA-N 0.000 description 1
- GVJKRJYEULLCOZ-IRLDBZIGSA-N CC(C)N(CC[C@H]1N(C(c2c(N3C[C@@H](c(cc(cc4)F)c4OC)OCCOC)[s]c(-[n]4nccn4)c2C)=O)C3=O)C1=O Chemical compound CC(C)N(CC[C@H]1N(C(c2c(N3C[C@@H](c(cc(cc4)F)c4OC)OCCOC)[s]c(-[n]4nccn4)c2C)=O)C3=O)C1=O GVJKRJYEULLCOZ-IRLDBZIGSA-N 0.000 description 1
- KIKTYQZUPCXXJL-SVQMELKDSA-N CC(CCN1C)(C1=O)N(C(c1c(N2C[C@@H](c3cc(F)ccc3OC)OCCOC)[s]c(-[n]3nccn3)c1C)=O)C2=O Chemical compound CC(CCN1C)(C1=O)N(C(c1c(N2C[C@@H](c3cc(F)ccc3OC)OCCOC)[s]c(-[n]3nccn3)c1C)=O)C2=O KIKTYQZUPCXXJL-SVQMELKDSA-N 0.000 description 1
- HADXUTFMHBNPAD-IJHRGXPZSA-N CCN(CCC1N(C(c2c(N3C[C@@H](c4cc(F)ccc4OC)OCCO)[s]c(-[n]4nccn4)c2C)=O)C3=O)C1=O Chemical compound CCN(CCC1N(C(c2c(N3C[C@@H](c4cc(F)ccc4OC)OCCO)[s]c(-[n]4nccn4)c2C)=O)C3=O)C1=O HADXUTFMHBNPAD-IJHRGXPZSA-N 0.000 description 1
- FUIXSSLUFDMWPL-UHFFFAOYSA-N CCOC(c1c(N)[s]c(-[n]2nccc2)c1C)=O Chemical compound CCOC(c1c(N)[s]c(-[n]2nccc2)c1C)=O FUIXSSLUFDMWPL-UHFFFAOYSA-N 0.000 description 1
- ZXQUAKUBBSEBCD-UHFFFAOYSA-N CCOC(c1c(NC(NC(CCCN2C)C2=O)=O)[s]c(-[n]2nccc2)c1C)=O Chemical compound CCOC(c1c(NC(NC(CCCN2C)C2=O)=O)[s]c(-[n]2nccc2)c1C)=O ZXQUAKUBBSEBCD-UHFFFAOYSA-N 0.000 description 1
- FSYXJZFACRSSHN-UHFFFAOYSA-N COCC/[O]=C(/CO)\c1cc(F)ccc1OC Chemical compound COCC/[O]=C(/CO)\c1cc(F)ccc1OC FSYXJZFACRSSHN-UHFFFAOYSA-N 0.000 description 1
- GNRCSWVAFGZUEK-LBPRGKRZSA-N COCCO[C@@H](CO)c1cc(F)ccc1OC Chemical compound COCCO[C@@H](CO)c1cc(F)ccc1OC GNRCSWVAFGZUEK-LBPRGKRZSA-N 0.000 description 1
- BHVKAQAGKAZQDP-UHFFFAOYSA-N COc(c(C(CBr)=O)c1)ccc1F Chemical compound COc(c(C(CBr)=O)c1)ccc1F BHVKAQAGKAZQDP-UHFFFAOYSA-N 0.000 description 1
- OOAXFRZNKMCFFE-UHFFFAOYSA-N COc(c(C(CO)OCCC=C)c1)ccc1F Chemical compound COc(c(C(CO)OCCC=C)c1)ccc1F OOAXFRZNKMCFFE-UHFFFAOYSA-N 0.000 description 1
- JREKZADIKXLMTG-AWEZNQCLSA-N COc(c([C@H](CO)OC1CCOCC1)c1)ccc1F Chemical compound COc(c([C@H](CO)OC1CCOCC1)c1)ccc1F JREKZADIKXLMTG-AWEZNQCLSA-N 0.000 description 1
- BRYPDTXWGDTQFO-AFMDSPMNSA-N C[C@@](CCN1)(C1=O)N(C(c1c(N2C[C@@H](c3cc(F)ccc3OC)OCCOC)[s]c(-[n]3nccn3)c1C)=O)C2=O Chemical compound C[C@@](CCN1)(C1=O)N(C(c1c(N2C[C@@H](c3cc(F)ccc3OC)OCCOC)[s]c(-[n]3nccn3)c1C)=O)C2=O BRYPDTXWGDTQFO-AFMDSPMNSA-N 0.000 description 1
- WZSBUEKTUOJESY-UHFFFAOYSA-N Cc1c(-[n]2nccc2)[s]c(N(CCc2cc(F)ccc2OC)C(N2C(CCCN3)C3=O)=O)c1C2=O Chemical compound Cc1c(-[n]2nccc2)[s]c(N(CCc2cc(F)ccc2OC)C(N2C(CCCN3)C3=O)=O)c1C2=O WZSBUEKTUOJESY-UHFFFAOYSA-N 0.000 description 1
- WZSBUEKTUOJESY-KRWDZBQOSA-N Cc1c(-[n]2nccc2)[s]c(N(CCc2cc(F)ccc2OC)C(N2[C@@H](CCCN3)C3=O)=O)c1C2=O Chemical compound Cc1c(-[n]2nccc2)[s]c(N(CCc2cc(F)ccc2OC)C(N2[C@@H](CCCN3)C3=O)=O)c1C2=O WZSBUEKTUOJESY-KRWDZBQOSA-N 0.000 description 1
- GCPLTXHYGKXOCK-IAXKEJLGSA-N Cc1c(-[n]2nccc2)[s]c(N(C[C@@H](c2cc(F)ccc2OC)OCCOC)C(N2C(CCCN3C)C3=O)=O)c1C2=O Chemical compound Cc1c(-[n]2nccc2)[s]c(N(C[C@@H](c2cc(F)ccc2OC)OCCOC)C(N2C(CCCN3C)C3=O)=O)c1C2=O GCPLTXHYGKXOCK-IAXKEJLGSA-N 0.000 description 1
- GCPLTXHYGKXOCK-IRLDBZIGSA-N Cc1c(-[n]2nccc2)[s]c(N(C[C@@H](c2cc(F)ccc2OC)OCCOC)C(N2[C@H](CCCN3C)C3=O)=O)c1C2=O Chemical compound Cc1c(-[n]2nccc2)[s]c(N(C[C@@H](c2cc(F)ccc2OC)OCCOC)C(N2[C@H](CCCN3C)C3=O)=O)c1C2=O GCPLTXHYGKXOCK-IRLDBZIGSA-N 0.000 description 1
- IJRYRLPORWOLOQ-UHFFFAOYSA-N Cc1c(-[n]2nccc2)[s]c(NC(N2C(CCCN3)C3=O)=O)c1C2=O Chemical compound Cc1c(-[n]2nccc2)[s]c(NC(N2C(CCCN3)C3=O)=O)c1C2=O IJRYRLPORWOLOQ-UHFFFAOYSA-N 0.000 description 1
- KBXCTPDWFJDQSH-CVMIBEPCSA-N Cc1c(-[n]2nccn2)[s]c(N(CC(/C=[O]/CCC(O)=O)c2cc(F)ccc2OC)C(N2[C@@H](CCN3C)C3=O)=O)c1C2=O Chemical compound Cc1c(-[n]2nccn2)[s]c(N(CC(/C=[O]/CCC(O)=O)c2cc(F)ccc2OC)C(N2[C@@H](CCN3C)C3=O)=O)c1C2=O KBXCTPDWFJDQSH-CVMIBEPCSA-N 0.000 description 1
- NBODGRXTWJWLMT-CQSZACIVSA-N Cc1c(-[n]2nccn2)[s]c(N(CC(c2cc(F)ccc2OC)=O)C(N2[C@H](CCN3)C3=O)=O)c1C2=O Chemical compound Cc1c(-[n]2nccn2)[s]c(N(CC(c2cc(F)ccc2OC)=O)C(N2[C@H](CCN3)C3=O)=O)c1C2=O NBODGRXTWJWLMT-CQSZACIVSA-N 0.000 description 1
- RLAYVLXTRPAUDR-OAHLLOKOSA-N Cc1c(-[n]2nccn2)[s]c(N(CC(c2cc(F)ccc2OC)=O)C(N2[C@H](CCN3C)C3=O)=O)c1C2=O Chemical compound Cc1c(-[n]2nccn2)[s]c(N(CC(c2cc(F)ccc2OC)=O)C(N2[C@H](CCN3C)C3=O)=O)c1C2=O RLAYVLXTRPAUDR-OAHLLOKOSA-N 0.000 description 1
- PXYHUIDTFMXEFX-HNNXBMFYSA-N Cc1c(-[n]2nccn2)[s]c(N(CCc2cc(F)ccc2OC)C(N2[C@@H](CCN3)C3=O)=O)c1C2=O Chemical compound Cc1c(-[n]2nccn2)[s]c(N(CCc2cc(F)ccc2OC)C(N2[C@@H](CCN3)C3=O)=O)c1C2=O PXYHUIDTFMXEFX-HNNXBMFYSA-N 0.000 description 1
- QGEUWDGMAIICFC-ICSRJNTNSA-N Cc1c(-[n]2nccn2)[s]c(N(C[C@@H](c(cc(cc2)F)c2OC)OCCOC)C(N2[C@@H](CCCN3)C3=O)=O)c1C2=O Chemical compound Cc1c(-[n]2nccn2)[s]c(N(C[C@@H](c(cc(cc2)F)c2OC)OCCOC)C(N2[C@@H](CCCN3)C3=O)=O)c1C2=O QGEUWDGMAIICFC-ICSRJNTNSA-N 0.000 description 1
- ZAHLWJLQISGEOI-APWZRJJASA-N Cc1c(-[n]2nccn2)[s]c(N(C[C@@H](c(cc(cc2)F)c2OC)OCCOC)C(N2[C@H](C3)CNC3=O)=O)c1C2=O Chemical compound Cc1c(-[n]2nccn2)[s]c(N(C[C@@H](c(cc(cc2)F)c2OC)OCCOC)C(N2[C@H](C3)CNC3=O)=O)c1C2=O ZAHLWJLQISGEOI-APWZRJJASA-N 0.000 description 1
- WZIJKOPWNUFBIH-NNBQYGFHSA-N Cc1c(-[n]2nccn2)[s]c(N(C[C@@H](c2cc(F)ccc2OC)OCCC(O)=O)C(N2C(CCCN3)C3=O)=O)c1C2=O Chemical compound Cc1c(-[n]2nccn2)[s]c(N(C[C@@H](c2cc(F)ccc2OC)OCCC(O)=O)C(N2C(CCCN3)C3=O)=O)c1C2=O WZIJKOPWNUFBIH-NNBQYGFHSA-N 0.000 description 1
- WZIJKOPWNUFBIH-MJGOQNOKSA-N Cc1c(-[n]2nccn2)[s]c(N(C[C@@H](c2cc(F)ccc2OC)OCCC(O)=O)C(N2[C@H](CCCN3)C3=O)=O)c1C2=O Chemical compound Cc1c(-[n]2nccn2)[s]c(N(C[C@@H](c2cc(F)ccc2OC)OCCC(O)=O)C(N2[C@H](CCCN3)C3=O)=O)c1C2=O WZIJKOPWNUFBIH-MJGOQNOKSA-N 0.000 description 1
- DECKFPXFYNGOJP-CVMIBEPCSA-N Cc1c(-[n]2nccn2)[s]c(N(C[C@@H](c2cc(F)ccc2OC)OCCO)C(N2C(C3)CN(C)C3=O)=O)c1C2=O Chemical compound Cc1c(-[n]2nccn2)[s]c(N(C[C@@H](c2cc(F)ccc2OC)OCCO)C(N2C(C3)CN(C)C3=O)=O)c1C2=O DECKFPXFYNGOJP-CVMIBEPCSA-N 0.000 description 1
- DECKFPXFYNGOJP-LPHOPBHVSA-N Cc1c(-[n]2nccn2)[s]c(N(C[C@@H](c2cc(F)ccc2OC)OCCO)C(N2[C@@H](C3)CN(C)C3=O)=O)c1C2=O Chemical compound Cc1c(-[n]2nccn2)[s]c(N(C[C@@H](c2cc(F)ccc2OC)OCCO)C(N2[C@@H](C3)CN(C)C3=O)=O)c1C2=O DECKFPXFYNGOJP-LPHOPBHVSA-N 0.000 description 1
- JIGWJMZRYPTTMJ-XLIONFOSSA-N Cc1c(-[n]2nccn2)[s]c(N(C[C@@H](c2cc(F)ccc2OC)OCCOC)C(N2[C@H](C3)CN(C)C3=O)=O)c1C2=O Chemical compound Cc1c(-[n]2nccn2)[s]c(N(C[C@@H](c2cc(F)ccc2OC)OCCOC)C(N2[C@H](C3)CN(C)C3=O)=O)c1C2=O JIGWJMZRYPTTMJ-XLIONFOSSA-N 0.000 description 1
- BPUYDWZNHIWXJW-UHFFFAOYSA-N Cc1c(-[n]2nccn2)[s]c(NC(N2C(CCCN3)C3=O)=O)c1C2=O Chemical compound Cc1c(-[n]2nccn2)[s]c(NC(N2C(CCCN3)C3=O)=O)c1C2=O BPUYDWZNHIWXJW-UHFFFAOYSA-N 0.000 description 1
- CWYDJCNBLIRUDA-ZETCQYMHSA-N Cc1c(-[n]2nccn2)[s]c(NC(N2[C@@H](CCN3)C3=O)=O)c1C2=O Chemical compound Cc1c(-[n]2nccn2)[s]c(NC(N2[C@@H](CCN3)C3=O)=O)c1C2=O CWYDJCNBLIRUDA-ZETCQYMHSA-N 0.000 description 1
- CWYDJCNBLIRUDA-SSDOTTSWSA-N Cc1c(-[n]2nccn2)[s]c(NC(N2[C@H](CCN3)C3=O)=O)c1C2=O Chemical compound Cc1c(-[n]2nccn2)[s]c(NC(N2[C@H](CCN3)C3=O)=O)c1C2=O CWYDJCNBLIRUDA-SSDOTTSWSA-N 0.000 description 1
- YXYPJSHUAXGGGE-QUCCMNQESA-N Cc1c(-c2ncc[o]2)[s]c(N(C[C@@H](c2cc(F)ccc2OC)OCCO)C(N2[C@H](CCCN3C)C3=O)=O)c1C2=O Chemical compound Cc1c(-c2ncc[o]2)[s]c(N(C[C@@H](c2cc(F)ccc2OC)OCCO)C(N2[C@H](CCCN3C)C3=O)=O)c1C2=O YXYPJSHUAXGGGE-QUCCMNQESA-N 0.000 description 1
- YCCMTCQQDULIFE-UHFFFAOYSA-N NC(CCCN1)C1=O Chemical compound NC(CCCN1)C1=O YCCMTCQQDULIFE-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/90—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having two or more relevant hetero rings, condensed among themselves or with a common carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Wood Science & Technology (AREA)
- Environmental Sciences (AREA)
- Zoology (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Child & Adolescent Psychology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562246318P | 2015-10-26 | 2015-10-26 | |
| US62/246,318 | 2015-10-26 | ||
| PCT/US2016/058867 WO2017075056A1 (en) | 2015-10-26 | 2016-10-26 | Acc inhibitors and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20180067603A true KR20180067603A (ko) | 2018-06-20 |
Family
ID=57233943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020187013132A Withdrawn KR20180067603A (ko) | 2015-10-26 | 2016-10-26 | Acc 억제제 및 그의 용도 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10179793B2 (https=) |
| EP (1) | EP3368540A1 (https=) |
| JP (1) | JP2018538246A (https=) |
| KR (1) | KR20180067603A (https=) |
| CN (1) | CN108368125A (https=) |
| AR (1) | AR106472A1 (https=) |
| AU (1) | AU2016344392A1 (https=) |
| BR (1) | BR112018008227A2 (https=) |
| CA (1) | CA3003275A1 (https=) |
| EA (1) | EA201890749A1 (https=) |
| IL (1) | IL258636A (https=) |
| MX (1) | MX2018005292A (https=) |
| SG (1) | SG11201802989QA (https=) |
| WO (1) | WO2017075056A1 (https=) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS57157B1 (sr) | 2011-11-11 | 2018-07-31 | Gilead Apollo Llc | Acc inhibitori i njihove primene |
| EP3225618B1 (en) | 2014-11-26 | 2020-05-06 | Takeda Pharmaceutical Company Limited | Bicyclic compound |
| BR112018009212B1 (pt) | 2015-11-25 | 2022-06-14 | Gilead Apollo, Llc | Método para controlar patógenos fúngicos agrícolas |
| PL3380479T3 (pl) | 2015-11-25 | 2023-05-08 | Gilead Apollo, Llc | Triazolowe inhibitory acc i ich zastosowania |
| AU2016361412A1 (en) | 2015-11-25 | 2018-05-24 | Gilead Apollo, Llc | Pyrazole ACC inhibitors and uses thereof |
| EA201890949A1 (ru) | 2015-11-25 | 2018-12-28 | Джилид Аполло, Ллс | СЛОЖНОЭФИРНЫЕ ИНГИБИТОРЫ АЦЕТИЛ-КоА-КАРБОКСИЛАЗЫ И ВАРИАНТЫ ИХ ПРИМЕНЕНИЯ |
| SG11201807077RA (en) * | 2016-03-02 | 2018-09-27 | Gilead Apollo Llc | Solid forms of a thienopyrimidinedione acc inhibitor and methods for production thereof |
| CA3037642A1 (en) | 2016-09-23 | 2018-03-29 | Bayer Aktiengesellschaft | N 3 -cyclically substituted thienouraciles and use thereof |
| EP3571205B1 (en) | 2017-01-22 | 2023-08-30 | Sunshine Lake Pharma Co., Ltd. | Thienopyrimidine derivative and use thereof in medicine |
| WO2018161008A1 (en) * | 2017-03-03 | 2018-09-07 | Gilead Apollo, Llc | Processes for the preparation of fungicidal compounds |
| SI4122464T1 (sl) | 2017-03-28 | 2024-07-31 | Gilead Sciences, Inc. | Terapevtske kombinacije za zdravljenje bolezni jeter |
| CN110709402B (zh) * | 2017-06-15 | 2022-05-10 | 浙江海正药业股份有限公司 | 杂芳基并嘧啶酮类衍生物、其制备方法及其在医药上用途 |
| TW201910338A (zh) * | 2017-07-26 | 2019-03-16 | 大陸商南京聖和藥業股份有限公司 | 作為acc抑制劑的化合物及其應用 |
| CA3094988A1 (en) | 2018-03-30 | 2019-10-03 | Biotheryx, Inc. | Thienopyrimidinone compounds |
| EP3805230B1 (en) * | 2018-06-05 | 2024-08-07 | Medshine Discovery Inc. | Thieno[2,3-c]pyridazin-4(1h)-one derivative and application thereof |
| CA3118422A1 (en) * | 2018-11-02 | 2020-05-07 | Dow Agrosciences Llc | Compositions comprising halauxifen and other herbicides and methods thereof |
| US20220041616A1 (en) * | 2018-11-20 | 2022-02-10 | The National Institutes of Pharmaceutical R&D Co., Ltd. | Spiro compound and medical uses thereof |
| CN111484504B (zh) * | 2019-01-25 | 2024-05-10 | 南京圣和药业股份有限公司 | Acc抑制剂的光学异构体及其应用 |
| US20220152164A1 (en) * | 2019-03-22 | 2022-05-19 | Kallyope, Inc. | Gpcr combination therapies |
| EP3995498A4 (en) | 2019-07-02 | 2023-03-01 | Sunshine Lake Pharma Co., Ltd. | THIENOPYRIMIDI DERIVATIVES WITH STEREO CONFIGURATION AND THEIR USE IN MEDICINE |
| AR119594A1 (es) | 2019-08-09 | 2021-12-29 | Gilead Sciences Inc | Derivados de tienopirimidina como inhibidores acc y usos de los mismos |
| CN110746439B (zh) * | 2019-10-18 | 2020-10-30 | 南京瑞捷医药科技有限公司 | 一种噻吩并嘧啶二酮化合物的制备方法 |
| CN114787166B (zh) * | 2019-12-05 | 2023-09-19 | 漳州片仔癀药业股份有限公司 | 噻吩并[2,3-c]哒嗪-4(1H)-酮类化合物的晶型及其制备方法和应用 |
| US11578081B1 (en) | 2019-12-05 | 2023-02-14 | Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. | Crystal form as inhibitor of ACC1 and ACC2, and preparation method therefor and use thereof |
| WO2021112213A1 (ja) * | 2019-12-05 | 2021-06-10 | 日本曹達株式会社 | ２，４－ジオキソ－１，４－ジヒドロチエノピリミジン化合物、及びそれを含有する農園芸用殺菌剤又は医療用・動物用抗真菌剤 |
| KR20230005210A (ko) * | 2020-04-08 | 2023-01-09 | 레믹스 테라퓨틱스 인크. | 스플라이싱을 조절하기 위한 화합물 및 방법 |
| US11478533B2 (en) | 2020-04-27 | 2022-10-25 | Novo Nordisk A/S | Semaglutide for use in medicine |
| CN113968871A (zh) * | 2020-07-25 | 2022-01-25 | 南京圣和药业股份有限公司 | 苯基取代类acc抑制剂的晶型 |
| WO2022133097A1 (en) * | 2020-12-17 | 2022-06-23 | Biogen Ma Inc. | Synthesis of compounds that modulate use-dependent voltage-gated sodium channels |
| WO2022138812A1 (ja) | 2020-12-24 | 2022-06-30 | モジュラス株式会社 | テトラヒドロチエノピリミジンスルホンアミド化合物 |
| WO2022268520A1 (de) * | 2021-06-21 | 2022-12-29 | Bayer Aktiengesellschaft | Verwendung von substituierten pyrrolidinonen oder deren salzen zur steigerung der stresstoleranz in pflanzen. |
| CN115677551A (zh) * | 2021-12-28 | 2023-02-03 | 武汉市振邦生物科技有限公司 | 一种2-氧代吡咯烷-3-甲酸乙酯的制备工艺 |
| WO2024031089A1 (en) | 2022-08-05 | 2024-02-08 | Gilead Sciences, Inc. | Sars-cov2 main protease inhibitors |
| CN115433756B (zh) * | 2022-08-30 | 2024-04-09 | 山东新华制药股份有限公司 | 一种泼尼松龙的制备方法 |
| TW202532074A (zh) * | 2024-02-07 | 2025-08-16 | 美商基利科學股份有限公司 | Ｓａｒｓ－ｃｏｖ２主要蛋白酶抑制劑 |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4670560A (en) | 1986-04-28 | 1987-06-02 | Ortho Pharmaceutical Corporation | Thienopyrimidine-2,4-dione derivatives and intermediates thereof |
| US4835157A (en) * | 1988-03-15 | 1989-05-30 | Ortho Pharmaceutical Corporation | Thieno- and furopyrimidine-2,4-dione piperidine derivatives as serotonin antagonists and alpha adrenergic blocking agents |
| JPH02225485A (ja) | 1989-02-27 | 1990-09-07 | Taiho Yakuhin Kogyo Kk | チエノピリミジン―３―酢酸誘導体 |
| JP3035745B2 (ja) * | 1990-02-22 | 2000-04-24 | 武田薬品工業株式会社 | 縮合チオフェン誘導体 |
| TW276256B (https=) | 1993-08-26 | 1996-05-21 | Takeda Pharm Industry Co Ltd | |
| JP3811196B2 (ja) | 1993-08-26 | 2006-08-16 | 武田薬品工業株式会社 | エンドセリン拮抗剤、チエノピリミジン誘導体およびその製造法 |
| EP0846119B1 (en) | 1995-08-17 | 2002-11-13 | Takeda Chemical Industries, Ltd. | Thienopyrimidine derivatives, their production and use as endothelin antagonists |
| JPH09110873A (ja) | 1995-08-17 | 1997-04-28 | Takeda Chem Ind Ltd | チエノピリミジン誘導体、その製造法および用途 |
| AU2407997A (en) | 1996-04-30 | 1997-11-19 | Takeda Chemical Industries Ltd. | Combined use of gnrh agonist and antagonist |
| JP2007302703A (ja) | 1996-04-30 | 2007-11-22 | Takeda Chem Ind Ltd | 医薬組成物 |
| US6984644B2 (en) | 1997-05-28 | 2006-01-10 | Astrazeneca Ab | Treatment of skin disorders using thieno[2,3-D]pyrimidinediones |
| SE9702001D0 (sv) | 1997-05-28 | 1997-05-28 | Astra Pharma Prod | Novel compounds |
| DE19754082A1 (de) | 1997-12-05 | 1999-06-10 | Knoll Ag | Methode zur Bekämpfung der Fettleibigkeit |
| US6166019A (en) * | 1998-07-16 | 2000-12-26 | Abbott Laboratories | Piperazinyl pyrimidine dione compounds selective for adrenoceptors |
| CA2369981A1 (en) | 1999-04-09 | 2000-10-19 | Cell Therapeutics, Inc. | Therapeutic compounds for inhibiting interleukin-12 signaling and methods for using same |
| EP1370562A1 (en) * | 2001-02-14 | 2003-12-17 | Warner-Lambert Company LLC | Thieno[2,3-d]pyrimidindione derivatives as matrix metalloproteinase inhibitors |
| US7655658B2 (en) | 2001-08-10 | 2010-02-02 | Palatin Technologies, Inc. | Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds |
| JP5072166B2 (ja) * | 2002-01-30 | 2012-11-14 | 武田薬品工業株式会社 | チエノピリミジン化合物、その製造法および用途 |
| CN1642599A (zh) | 2002-02-27 | 2005-07-20 | 辉瑞产品公司 | Acc抑制剂 |
| AU2003253165A1 (en) | 2002-08-13 | 2004-02-25 | Warner-Lambert Company Llc | Pyrimidine fused bicyclic metalloproteinase inhibitors |
| WO2004060058A2 (en) | 2003-01-06 | 2004-07-22 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Herbicides inhibiting the action of plant acetyl-coa carboxylase for use as pesticides. |
| EP1591446B1 (en) | 2003-01-29 | 2013-03-06 | Takeda Pharmaceutical Company Limited | Thienopyrimidine compounds and use thereof |
| US7947691B2 (en) | 2004-07-21 | 2011-05-24 | Athersys, Inc. | Cyclic n-hydroxy imides as inhibitors of flap endonuclease and uses thereof |
| CA2644996A1 (en) | 2006-03-02 | 2007-09-13 | Cv Therapeutics, Inc. | A2a adenosine receptor antagonists |
| JPWO2008143262A1 (ja) | 2007-05-21 | 2010-08-12 | 武田薬品工業株式会社 | 複素環化合物およびその用途 |
| WO2010050445A1 (ja) | 2008-10-27 | 2010-05-06 | 武田薬品工業株式会社 | 二環性化合物 |
| DK2519527T3 (da) | 2009-12-29 | 2014-01-27 | Poxel | Thieno[2,3-b]pyridindion-aktivatorer af ampk og terapeutiske anvendelser deraf |
| EP2569450A4 (en) * | 2010-05-14 | 2013-12-25 | Univ Rochester | COMPOSITIONS AND METHODS FOR TARGETING A3G: RNA COMPLEXES |
| RS57157B1 (sr) | 2011-11-11 | 2018-07-31 | Gilead Apollo Llc | Acc inhibitori i njihove primene |
| EP2994139B1 (en) | 2013-05-10 | 2019-04-10 | Gilead Apollo, LLC | Acc inhibitors and uses thereof |
| JP6417402B2 (ja) | 2013-05-10 | 2018-11-07 | ギリアド アポロ， エルエルシー | Ａｃｃ阻害剤及びその使用 |
| JP6417401B2 (ja) * | 2013-05-10 | 2018-11-07 | ギリアド アポロ， エルエルシー | Ａｃｃ阻害剤及びその使用 |
| AU2014262547A1 (en) | 2013-05-10 | 2015-11-26 | Gilead Apollo, Llc | ACC inhibitors and uses thereof |
| TWI652012B (zh) | 2013-05-20 | 2019-03-01 | 杜邦股份有限公司 | 殺真菌吡唑的固態形式 |
| WO2015007451A1 (en) * | 2013-07-15 | 2015-01-22 | Syngenta Participations Ag | Microbiocidal heterobicyclic derivatives |
| WO2015007453A1 (en) * | 2013-07-15 | 2015-01-22 | Syngenta Participations Ag | Microbiocidal heterobicyclic derivatives |
| AU2016361412A1 (en) | 2015-11-25 | 2018-05-24 | Gilead Apollo, Llc | Pyrazole ACC inhibitors and uses thereof |
| BR112018009212B1 (pt) | 2015-11-25 | 2022-06-14 | Gilead Apollo, Llc | Método para controlar patógenos fúngicos agrícolas |
| PL3380479T3 (pl) | 2015-11-25 | 2023-05-08 | Gilead Apollo, Llc | Triazolowe inhibitory acc i ich zastosowania |
| EA201890949A1 (ru) | 2015-11-25 | 2018-12-28 | Джилид Аполло, Ллс | СЛОЖНОЭФИРНЫЕ ИНГИБИТОРЫ АЦЕТИЛ-КоА-КАРБОКСИЛАЗЫ И ВАРИАНТЫ ИХ ПРИМЕНЕНИЯ |
| SG11201807077RA (en) | 2016-03-02 | 2018-09-27 | Gilead Apollo Llc | Solid forms of a thienopyrimidinedione acc inhibitor and methods for production thereof |
-
2016
- 2016-10-25 AR ARP160103255A patent/AR106472A1/es unknown
- 2016-10-26 CN CN201680072737.1A patent/CN108368125A/zh active Pending
- 2016-10-26 JP JP2018521087A patent/JP2018538246A/ja active Pending
- 2016-10-26 EP EP16791253.4A patent/EP3368540A1/en not_active Withdrawn
- 2016-10-26 US US15/334,955 patent/US10179793B2/en not_active Expired - Fee Related
- 2016-10-26 MX MX2018005292A patent/MX2018005292A/es unknown
- 2016-10-26 KR KR1020187013132A patent/KR20180067603A/ko not_active Withdrawn
- 2016-10-26 CA CA3003275A patent/CA3003275A1/en not_active Abandoned
- 2016-10-26 BR BR112018008227A patent/BR112018008227A2/pt not_active Application Discontinuation
- 2016-10-26 WO PCT/US2016/058867 patent/WO2017075056A1/en not_active Ceased
- 2016-10-26 AU AU2016344392A patent/AU2016344392A1/en not_active Abandoned
- 2016-10-26 SG SG11201802989QA patent/SG11201802989QA/en unknown
- 2016-10-26 EA EA201890749A patent/EA201890749A1/ru unknown
-
2018
- 2018-04-11 IL IL258636A patent/IL258636A/en unknown
- 2018-11-27 US US16/201,571 patent/US20190330224A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP3368540A1 (en) | 2018-09-05 |
| MX2018005292A (es) | 2018-08-01 |
| CN108368125A (zh) | 2018-08-03 |
| IL258636A (en) | 2018-06-28 |
| WO2017075056A1 (en) | 2017-05-04 |
| AU2016344392A1 (en) | 2018-05-10 |
| EA201890749A1 (ru) | 2018-11-30 |
| US20190330224A1 (en) | 2019-10-31 |
| CA3003275A1 (en) | 2017-05-04 |
| SG11201802989QA (en) | 2018-05-30 |
| BR112018008227A2 (pt) | 2018-10-23 |
| JP2018538246A (ja) | 2018-12-27 |
| US10179793B2 (en) | 2019-01-15 |
| AR106472A1 (es) | 2018-01-17 |
| US20170145028A1 (en) | 2017-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10800791B2 (en) | Triazole ACC inhibitors and uses thereof | |
| US10179793B2 (en) | ACC inhibitors and uses thereof | |
| US10472374B2 (en) | ACC inhibitors and uses thereof | |
| KR20180082556A (ko) | 피라졸 acc 억제제 및 그의 용도 | |
| KR20180082558A (ko) | 에스테르 acc 억제제 및 그의 용도 | |
| HK40026833B (en) | Acc inhibitors and uses thereof | |
| NZ738735B2 (en) | ACC inhibitors and uses thereof | |
| HK1201207B (en) | Acc inhibitors and uses thereof | |
| TW201400489A (zh) | Ａｃｃ抑制劑及彼等之用途 | |
| NZ624819B2 (en) | Acc inhibitors and uses thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20180509 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PC1203 | Withdrawal of no request for examination | ||
| WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |